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ABSTRACT
Telomeres protect chromosome ends from being
recognized as double-stranded breaks. Telomeric
function is ensured by the shelterin complex in
which TRF2 protein is an essential player. The
G-rich strand of telomere DNA can fold into
G-quadruplex (G4) structure. Small molecules
stabilizing G4 structures, named G4 ligands, have
been shown to alter telomeric functions in human
cells. In this study, we show that a guanine-rich
RNA sequence located in the 50-UTR region of the
TRF2 mRNA (hereafter 91TRF2G) is capable of
forming a stable quadruplex that causes a 2.8-fold
decrease in the translation of a reporter gene in
human cells, as compared to a mutant 50-UTR
unable to fold into G4. We also demonstrate that
several highly selective G4 ligands, the pyridine
dicarboxamide derivative 360A and bisquinolinium
compounds Phen-DC(3) and Phen-DC(6), are able
to bind the 91TRF2G:RNA sequence and to
modulate TRF2 protein translation in vitro. Since
the naturally occurring 50-UTR TRF2:RNA G4
element was used here, which is conserved in
several vertebrate orthologs, the present data sub-
stantiate a potential translational mechanism
mediated by a G4 RNA motif for the downregulation
of TRF2 expression.
INTRODUCTION
In vitro, single-stranded G-rich nucleic acid sequences can
adopt an unusual conformation called a G4-quadruplex
(G4) (1). G4 structures result from the successive stacking
of G-quartet formed by four guanines located on a plan
and interacting by Hoogsteen hydrogen bonds (2). The
formation of G4 structures is strongly dependent on
monovalent cations such K
+and Na
+and, hence, physio-
logical buffer conditions favor their formation (3). G4
structures can be formed by one or more nucleic acid
strands. Numerous physical analyses have revealed that
G4 structures are highly polymorphic and can be sub-
grouped into various families, such as parallel or antipar-
allel, according to the orientation of the strands (4–6).
In vitro, G4 structures are selectively bound and stabilized
by small molecules called G4 ligands (7).
The existence of G4s has been demonstrated in vivo in
ciliates using speciﬁc antibodies (8), whereas only indirect
evidence sustained their existence in mammalian cells [for
a review see (9,10)]. Bioinformatic analysis of the human
genome indicated that it contains as many as 370000 se-
quences possessing the Potential G-Quadruplex-forming
Sequences (PQS) (11,12). As expected, most of these se-
quences are located in repetitive DNA regions, such as
telomeres and rDNA. In addition, a statistically signiﬁ-
cant enrichment of PQS was found in regulatory regions
such as gene promoters (13), splice sequences and UTRs
regions (14) raising the possibility that G4 structures could
play a role in the regulation of gene expression.
In eukaryotes, chromosomes ends are protected from
DNA repair systems by a particular nucleoprotein struc-
ture, the telomere (15). In humans, the telomere is
composed of thousands of G-rich double-stranded TTA
GGG repeats (16) and a 30 single-stranded G-rich exten-
sion called the G-tail or G-overhang (17). The telomeric
DNA is bound by a telomere-speciﬁc six-protein complex
called shelterin (18). Shelterin stabilizes a special DNA
structure, the t-loop, in which the G-tail invades the
duplex telomeric repeats, forming a D-loop structure
(18). The t-loop masks chromosome ends and
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telomeres (19).
TRF2 protein plays an essential role in the shelterin
function (18). TRF2 has been shown to promote and sta-
bilize loop formation (20). In conjunction with its partner
RAP1, TRF2 also triggers the inhibition of the the non
homologous end joining relying on the DNA-dependent
protein kinase at telomeres (21). Thus, overexpression of
dominant-negative mutants of TRF2 induces telomere
uncapping triggering end-to-end chromosome fusions
(22) or stochastic deletions of telomeric DNA through a
homologous recombination-mediated mechanism (23).
TRF2 is overexpressed in several human tumors, such as
liver hepatocarcinomas (24), breast carcinomas (25) and
lung carcinomas (26), suggesting that TRF2 may play a
role in tumorigenesis.
In this study, we describe the biophysical and functional
characterization of G-rich sequences present within the
TRF2 mRNA. We show that a G-rich sequence located
in the 50-UTR region of the TRF2 mRNA adopts a stable
intramolecular G4 RNA structure in vitro, which is able to
repress the expression of a reporter gene in vitro and in
cells. Mutation of this sequence impairing quadruplex sta-
bilization leads to an increased expression.
Furthermore, using biophysical analyses, we show that
the G-quadruplex RNA motif adopted by the G-rich
sequence located within the 50-UTR of TRF2 mRNA is
bound by several highly selective G-quadruplex ligands.
In vitro studies show that the stabilization of the G4
RNA motif has a signiﬁcant effect on the expression of
a reporter gene. These data suggest that G4 formation in
the 50-UTR from TRF2 represents a new mechanism to
control TRF2 expression.
MATERIALS AND METHODS
Oligonucleotides
All oligonucleotides described in Table 1 except
+75UTRATGTRF2 and mut+75UTRATGTRF2
(Sigma Aldrich) were purchased from Eurogentec.
Circular dichroism measurements
Circular dichroism (CD) spectra were recorded on a
JASCO-810 spectropolarimeter using 1-cm path length
quartz cuvettes in a reaction volume of 580ml, as previ-
ously described (27). Oligonucleotides 91TRF2G:RNA
and mut91TRF2G:RNA (Table 1) were prepared as a
4mM solution in 10mM lithium cacodylate pH 7.2,
100mM NaCl or KCl buffer and annealed by heating to
90 C for 2min, followed by slow cooling to 20 C.
Scans were performed at 20 C over a wavelength range
of 235–350nm with a scanning speed of 500nm/min,
a response time of 1s, 1nm data pitch and 1nm
bandwidth.
UV melting assays for G4s
Oligonucleotides 91TRF2G:RNA and mut91TRF2G:
RNA (Table 1) were synthesized by Eurogentec
(Seraing, Belgium) at the 200 nmol scale and used
without further puriﬁcation. Concentrations were
estimated using extinction coefﬁcients provided by the
manufacturer. Melting assays were performed on a
Uvikon 940 spectrophotometer in a 10mM lithium caco-
dylate pH 7.2 buffer (supplemented with either 0.1M KCl
or NaCl, hereafter referred to as potassium and sodium
conditions, respectively), as previously described (28–30).
Melting experiments were typically performed at a con-
centration of 4mM per strand. All transitions were revers-
ible, as shown by superimposable heating and cooling
proﬁles at a ﬁxed rate of 0.2 C/min.
FRET melting of F21T
Tm of F21T (0.2mM) was recorded alone, in the presence
of 1mM of G4 ligands, in the presence of 3mM competitor
or in presence of G4 ligands+competitor. The competi-
tors were a double-stranded (ds26:50-CAATCGGATCGA
ATTCGATCCGATTG-30), or 91TRF2G:RNA or
Mut91TRF2G:RNA. All experiments were performed in
duplicate. The emission of ﬂuorescein is normalized
between 0 and 1, and the T1/2 is deﬁned as the temperature
for which the normalized emission is 0.5 (31).
Gel electrophoresis
Formation of G4 RNA was conﬁrmed by nondenaturing
PAGE. Oligonucleotides were directly visualized by UV
shadow (see Supplementary Data). Prior to the incuba-
tion, the DNA samples were heated at 90 C for 5min
and slowly cooled (2h) to room temperature. Samples
were incubated at 30mM strand concentration in Tris–
HCl 10mM pH 7.5 buffer with 100mM Na
+ or K
+. Ten
percent sucrose was added just before loading.
Oligothymidylate markers (dT15,d T 21 or dT30)o r
double-stranded markers (Dx9:50-d-GCGTATCG
G+50-d-CCGATACGC; Dx12:50-d-GCGTGACTTCGG
+50-d-CCGAAGTCACGC) were also loaded on the gel.
One should note that the migration of the dTn oligo-
nucleotides does not necessarily correspond to single
strands (32): these oligonucleotides were chosen here to
provide an internal migration standard, not to identify
intramolecular or higher order structures.
Table 1. Sequence of the oligonucleotides used for this study
91TRF2:DNA GGGAGGGCGGGGAGGG
131TRF2:DNA GGGAGGAGGCGGGAGTAGCGACGGCAGCGGGCGGG
195TRF2:DNA GGGCGGGCCCGGCGGGGGCGCCACGAGCCGGGG
199TRF2:DNA GGGCCCGGCGGGGGCGCCACGAGCCGGGGCTGGGGGG
91TRF2G:RNA CGGGAGGGCGGGGAGGGC
mut91TRF2G:RNA CGUGAGUGCGCUGAGGGC
+75UTRATGTRF2 GATCCGCCGAGGAAGCGGCCCGGCCGGGAGGGCGGGGAGGGCGCGCGGCGATCGGACACGGAATTCATG
mut+75UTRATGTRF2 GATCCGCCGAGGAAGCGGCCCGGCCGTGAGTGCGCTGAGGGCGCGCGGCGATCGGACACGGAATTCATG
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To construct pWUTRF2 and pMUTRF2 plasmids, a
synthetic DNA duplex carrying either the
+65UTRATGTRF2 or the mut+65UTRATGTRF2
sequence was inserted at the BamHI–EcoRI sites within
the pcDNA3 vector (Invitrogen). The resulting plasmids
were utilized to clone an EcoRI–XhoI DNA fragment
encoding the green ﬂuorescent protein (GFP) obtained
by PCR ampliﬁcation of the GFP sequence from
pEGFP-C1 plasmid (Clontech). The insertion of correct
sequences was veriﬁed by sequencing.
TRF2B construction result from the insertion of a 50
deleted form of TRF2 cDNA (23) into the BamHI–EcoR1
sites of the pcDNA3 plasmid (Invitrogen).
In vitro transcription and translation
In vitro coupled transcription–translation of pWUTRF2
and pMTRF2 plasmids was carried out using the rabbit
reticulocyte lysate-based transcription–translation
coupled system (TNT Quick Coupled Transcription/
Translation System, Promega) according to the manufac-
turer’s instructions. Brieﬂy, a 1mg plasmid mixture con-
sisting of 0.2mg of the TRF2B plasmid and either 0.8mg
of pWUTRF2 or pMUTRF2 plasmid was mixed to
12.5ml of TNT rabbit reticulocyte system, 1ml of TNT
reaction buffer, 0.5ml of amino acid mixture minus me-
thionine, 1mlo f[
35S]-L-methionine at 1175Ci/mmol
(PerkinElmer) and 0.5ml of T7 RNA polymerase in a
total reaction volume of 25ml. The reaction mixture was
incubated at 30 C for 90min and immediately put at
 20 C. To evaluate GFP production, 5ml of each
reaction was diluted 5-fold with 1X Laemmli buffer,
heated at 70 C for 10min and loaded on a 12% SDS–
polyacrylamide gel. After separation, [
35S]-methionine in-
corporation was visualized by a Phosphorimager
(Typhoon 9210 Amersham). To study the effect of G4
ligands on in vitro gene expression indicated, concentra-
tions of molecules (in a volume of 2.5ml) were added to the
complete reaction mixture before incubation at 30 C.
Cell culture and transfection
The 293T cells were growth at 37 C in a humidiﬁed
atmosphere containing 5% CO2 in Dulbecco’s modiﬁed
Eagles medium supplemented with 10% heat-inactivated
fetal calf serum and the antibiotics penicillin and
streptomycin.
Transfection was carried out in six-well plates using 3mg
of each plasmid and Lipofectamine 2000 (Invitrogen)
transfectant reagent according to the manufacturer’s in-
structions. Twenty-four hours after transfection, cells
were recovered by trypsination and the cellular pellet was
divided into two equal portions to proceed to western blot
and Quantitative real time PCR (RT–qPCR) analyses.
Western blotting
SDS gel electrophoresis was performed in a 12% poly-
acrylamide gels with a protein content of 50mg at 150V
in 0.025M Tris pH 8.3, 0.192M glycine, 0.1% SDS. Gels
were blotted onto Immobilon-P polyvinylidene diﬂuoride
membrane (Millipore). The membrane was blocked with
5% dry milk in PBS-T [(1  phosphate buffer saline, 0.1%
v/v Tween-20 (Sigma-Aldrich)] for 30min at room tem-
perature and incubated with the anti-GFP primary
antibody (1:1000 in 1  phosphate buffer saline,
0.1% v/v Tween-20) for 1h at room temperature. A sec-
ondary horseradish peroxidase conjugated antibody
(1:10000, 45min at room temperature) was used and
detected using the enhanced chemiluminescence kit
(ImmunofaxA, Yelen).
Quantitative real-time PCR assay
Total cellular RNA was isolated using RNeasy Plus Mini
Kit (Qiagen). For quantiﬁcation of mRNA levels, 1mgo f
total RNA was used in a 20ml reverse transcription
reaction using the RevertAid H Minus First Strand
cDNA synthesis Kit (Fermentas) in the presence of
random hexamer. A control reaction, without reverse
transcriptase enzyme, was performed in parallel to
ensure the absence of plasmid DNA contamination.
Real-time PCR was performed with 25ng of cDNA and
300nM concentration of both sense and antisense GFP
primers (sense 50-CGACCACATGAAGCAG and anti-
sense 50-TCCTGGACGTAGCCTTCGG) in a ﬁnal
volume of 25ml using the SYBR Green TaqMan
Universal PCR master mix (Applied Biosystems).
Fluorescence was monitored and analyzed in a
GeneAmp 7300 detection system instrument (Applied
Biosystems). Analysis of 18S ribosomal RNA and
GAPDH RNA (Applied Biosystems TaqMan probes)
was performed in parallel to normalize for gene expression.
For RNA quantiﬁcation of in vitro transcription/trans-
lation products, 5ml of this mix was used in 20ml reverse
transcription reaction. Real-time PCR was performed
with 5ml of reverse transcription products.
RESULTS
Putative G4 elements within the 50-part of the human
TRF2 mRNA
Sequence analysis of the 50-part of the human TRF2
mRNA shows the presence of several G-rich sequences
surrounding the AUG start codon (Figure 1A).
Bioinformatic analysis of the TRF2 mRNA using
QGRS Mapper program (33) shows the existence of
several potential G4 structures within the 50-part of the
TRF2 mRNA. Two sequences present high G-score and
are favorable for G4 folding: the ﬁrst one matching the
sequence 50-GGGAGGGCGGGGAGGG-30 (91TRF2G)
is located within the 50-UTR, 19nt upstream of the AUG
start codon and the second one matching the sequence
50-GGGCCCGGCGGGGGCGCCACGAGCCGGGGC
UGGGGGG-30 (199TRF2G) at 66nt downstream of the
translation start site. The DNA sequence alignment of
human TRF2 with its orthologs present in six amniota
vertebrates shows that the G-rich sequence present in
the 50-UTR of human TRF2 is evolutionarily conserved
across species (Figure 1B), indicating a potential regula-
tory role. Thus we decided to further characterize these
sequences, both at the molecular and functional level.
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quences may adopt a G4 DNA structure in vitro, we per-
formed a rapid screening by electrophoretic mobility
shift assays with several DNA oligonucleotides designed
from the PQS (91TRF2G:DNA, 131TRF2G:DNA,
195TRF2G:DNA and 199TRF2G:DNA; see Table 1)
and puriﬁed recombinant human Topoisomerase IIIa
(Topo III), in the presence of increasing concentrations
of the 360A pyridine dicarboxamide derivative, a potent
and highly speciﬁc G4 ligand (Supplementary Figure S1
and Supplementary Data).
We conclude from these experiments that
91TRF2G:DNA sequence is the best candidate in the
50-UTR of the TRF2 mRNA to adopt a G4 DNA struc-
ture in vitro, and we decided to further characterize its
biophysical and biological properties.
91TRF2G sequence adopt a G4 RNA structure of
extreme stability
To test whether the 91TRF2G sequence forms a G4 RNA
structure, we carried out biophysical analyses on the RNA
oligonucleotide 50-CGGGAGGGCGGGGAGGGC-30.
CD experiments using different ionic conditions (Na
+,
K
+ and Li
+) at physiological pH (see ‘Materials and
Methods’ section) were performed, and spectra show the
characteristic features of parallel G4 structures, with a
positive peak at 263nm and a trough at 240nm the amp-
litude of which is higher in Na
+or K
+conditions than in
Li
+(Figure 2A) (34). Under the same conditions, thermal
difference spectrum analysis of the 91TRF2G:RNA is
characterized by a negative minima at 262 and 295nm,
positive maxima at 255 and 270nm, a shoulder at
245nm, which are the particular signatures of the G4
structures (data not shown) (29).
The thermal melting of quadruplex nucleic acids can
be characterized by an inverse UV transition at
295nm, and has generally been found to have signiﬁ-
cant and characteristic cation dependence. The monova-
lent ion dependence for the stabilization of folded
91TRF2G:RNA as judged by Tm, was in the order
K
+>Na
+>Li
+ (Table 2), which is characteristic of G4
nucleic acids (3).
At 100mM KCl, the folded 91TRF2G RNA
quadruplex could not be unfolded, even at 95 C, which
is indicative of a very stable quadruplex. The 91TRF2G
G4 RNA was very stable (Tm=61.58 C) even in the
presence of low-salt concentrations (1mM KCl). Studies
over a 10-fold strand concentration range (from 2 to
20mM) showed no change in the Tm-value (Table 3), this
last result being consistent with the folding of an intramo-
lecular quadruplex.
TGGCCGCGGGAGCCGGGACGGCGGGCCCCGCTTCCGGCCCGGGCGTCGTGCGTGACCCAGCGGCGTCACAGCCGAGGAAG
CGGCCCGGCCGGGAGGGCGGGGAGGGCGCGCGGCGATCGGACACG-ATG-GCGGGAGGAGGCGGGAGTAGCGACGGCAGC
GGGCGGGCAGCTGGCAGGCGGGCGTCCCGCAGTAGCGGGCGGGCCCGGCGGGGGCGCCACGAGCCGGGGCTGGGGGGCCC
GGCGGAGCGCGGCGCGGGGGAGGCACGGCTGGAAGAGGCAGTCAATCGCTGGGTGCTCAAGT
+1
91TRF2G
199TRF2G
Homo_sapiens 16: 69419759 --------- CGGCCGGGAGGGCGGGGAGGGCGCGCGGCGATCGGACACG ATG GCGGGAGGAGGCGGGAGTAGCGACGGCAGCGGGCGGGCAGCTGGC 
Pan_troglodytes 16: 69206693 ------- CGGCCGGGAGGGCGGGGAGGGCGCGCGGCGATCGGACACG ATG GCGGGAGGAGGCGGGAGTAGCGACGGCAGCGGGCGGGCAGCTGGC 
Pongo_pygmaeus 16: 56793570 -------- CGGCCGGGAGGGCGGGGAGGGCGCGCGGCGATCGGACGCG ATG GCGGGAGGAGGCGGGAGTAGCGACGGCAGCGGGCGGGCAGCTGGC 
Macaca_mulatta 20: 67763468 -------- CGGCCGGGAGGGCGGGGAGGGCGCGCGGCGATCGGACGCG ATG GCGGGAGGAGGCGGGAGCAGCGACGGCAGCGGGCGGGCAGCTGGC 
Mus_musculus 8:109620285 --- CAGTCGGGAGGGCGGGGAGGGCGGGGAGGGCGAGCGGCGGTCGAACACG ATG GCGGGAGGAGGCGGGAGCAGCGATAGCAGCGGGCGGGCGGCGAGC 
Canis_familiaris 5: 83286686 ------- CGGCCGGGAAGGCGGGGAGGGCGCGCGGCGATCGGACGCG ATG GCGGGAGGAGGCGGGAGCAGCGACGGCAGCGGGCGGGCGGCAGGC
Bos_taurus 18: 35534646 --------- CGGCAGGGAGGGCGGGGAGGGCGCGCGGCGATCAGACGCG ATG GCGGGAGGAGGCGGGAGCAGCGACAGCAGCGGGAGGGCGGCAGGC
A
B
Figure 1. Sequence analysis of the 50-part of the TRF2 cDNA. (A) G-rich sequences corresponding to the consensus 50-G3-Nx-G3-Nx-G3-Nx-G3-30
are in a gray background. The 191TRF2G and 199TRF2G sequences (G4 structures predicted by QGRS Mapper software) and translation start site
are indicated. (B) Conservation of the 91TRF2G motif in the 50-UTR of TRF2. Nucleotides underlined are runs of guanines able to form G4s.
Table 2. Tm-values for 91TRF2G:RNA in the presence of various
cations
Name Tm
a
100mM
Li
+
100mM
Na
+
10mM
K
+
5mM
K
+
1mM
K
+
91TRF2G:RNA
b 39.5 64.0 >77.0 72.0 61.8
Mut91TRF2G:RNA
b  
c  
c  
c  
c  
c
For all experiments, the buffer consisted of 10mM lithium cacodylate
(pH 7.2) in the presence of the indicated cation. Tm-values were
obtained by measuring the inverted UV transition at 295nm (30)
aTm in  C, with ±0.5 C precision; determined from the analysis of UV
melting proﬁles at 295nm.
bOligonucleotides were prepared at 4mM in 10mM lithium cacodylate
buffer at pH 7.2.
cThis sequence does not form a quadruplex.
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bonding established between guanines. Thus, single
guanine replacements in the 91TRF2G:RNA sequence
should prevent the folding of this sequence in a G4
RNA structure. Mut91TRF2G:RNA sequence 50
CGUGAGUGCGCUGAGGGC 30 was designed by
replacing four key guanine nucleotides present in the
91TRF2G:RNA sequence at positions G3, G7, G11 and
G12. As shown in Figure 2B, CD spectrum analysis of
Mut91TRF2G sequence, in the presence of Na
+ or K
+
ionic concentrations, did not show the main features
associated to G4 formation. In addition, native gel elec-
trophoresis revealed that Mut91TRF2G:RNA migrates at
its expected molecular weight position, as compared to
91TRF2G:RNA whose migration is lowered, as expected
for a G4 structure (Supplementary Figure S2).
Altogether, these data indicate that under near-
physiological pH and salt conditions, 91TRF2G:RNA
folds into a very stable, intramolecular G4 RNA that
presents the characteristic features of a parallel G4.
Since CD spectra only provide indirect evidence for G4
topology, additional experiments are necessary to conﬁrm
this ﬁnding.
91TRF2G sequence inhibits translation of GFP both
in vitro and in vivo
To evaluate the impact of the G4 structure formed by the
91TRF2G sequence on gene expression, we cloned the
62nt of the 50-UTR from TRF2, containing either
the wild-type 91TRF2G sequence (plasmid pWUTRF2)
or its mutated version Mut91TRF2G (plasmid
pMUTRF2), upstream of the GFP-coding sequence and
immediately downstream of the minimal T7 promoter
present on pcDNA3 plasmid (Figure 3A). Using an
in vitro coupled transcription–translation assay, based on
rabbit reticulocyte lysate system, the GFP expression re-
sulting from these constructions was evaluated by radio-
active quantiﬁcation of [
35S]-methionine incorporation
and showed a 2.45-fold increase in GFP synthesis for
the mutated sequence relative to the wild-type sequence
(Figure 3B and C). To further characterize the repressive
effect of 91TRF2G sequence on gene expression in vitro,
we next proceeded to quantiﬁcation of RNA molecules
produced by the transcription–translation coupled
system. As shown in Figure 3D, RT-PCR analysis did
not show any signiﬁcant difference of the in vitro tran-
scription of two constructions. This result indicates that
the presence of a G4 sequence within the 50-UTR of
the gene reporter construction does not affect the tran-
scriptional process. Together, these results suggest
that the presence of a G4 motif within the 50-UTR of
the TRF2 mRNA inhibits the gene expression at a
posttranscriptional level.
In order to investigate the impact of 91TRF2G G4
structure in a cellular context, 293T cells were transfected
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Figure 2. CD spectra of (A) 91TRF2:RNA and (B) Mut91TRF2:RNA sequences. CD spectra were recorded at 20 C on a JASCO-810 using 1-cm
path length quartz cuvettes. Oligonucleotides were prepared as a 4mM and annealed by heating to 90 C for 2min, followed by slow cooling to 20 C.
Buffers containing 10mM lithium cacodylate at pH 7.2 supplemented with the indicated cation.
Table 3. Tm-values for 91TRF2G:RNA at various concentrations
Name Tm
a
2mM4 mM1 0 mM2 0 mM
91TRF2G:RNA
b 78.0 >77.0 77.5 78.0
For all experiments, the buffer consisted of 10mM lithium cacodylate
(pH 7.2) in the presence of 10mM KCl. Tm-values were obtained by
measuring the inverted UV transition at 295nm (30).
aTm in  C, with ±0.5 C precision; determined from the analysis of UV
melting proﬁles at 295nm.
bOligonucleotide tested at four strand concentrations (2mM, 4mM,
10mM and 20mM) in 10mM lithium cacodylate buffer at pH 7.2
with 10mM KCl and 90mM LiCl.
Nucleic Acids Research, 2010,Vol.38, No. 20 7191with plasmids pWUTRF2 or pMUTRF2. Twenty-four
hours after transfection, cells were harvested and protein
lysates were prepared. Western blot analysis of GFP ex-
pression indicated that 293T cells transfected by
pMUTRF2 present a 2.8-fold higher GFP protein level
(normalized to actin), as compared to the signal
obtained using pWUTRF2 (Figure 4A). As RNA
quadruplexes in genes promoters have been reported to
modulate transcription levels of several genes (35–37),
and to exclude any variation due to the transfection efﬁ-
ciency, mRNA levels arising from transcription of
pWUTRF2 and pMUTRF2 plasmids were quantiﬁed
using RT–qPCR assays. Relative quantiﬁcation of GFP
mRNA molecules produced by pWUTRF2 or pWUTRF2
showed no signiﬁcant difference of the transcriptional ex-
pression between the two constructions (Figure 4B). This
result together with our in vitro data showing the forma-
tion of a highly stable parallel G4 RNA structure under
physiological conditions for 91TRF2G:RNA strongly
suggest that the repression of GFP expression observed
in vivo is due to the ability of 91TRF2G:RNA G4 struc-
ture to reduce translation in human cells.
91TRF2G:RNA G4 structure is bound by G4 ligands
in vitro
The interaction of the 91TRF2G:RNA sequence with G4
ligands has been investigated by a competition FRET
assay using a real-time PCR apparatus and the doubly
labelled F21T oligonucleotide which mimics the human
telomeric single-strand overhang, as previously described
by Mergny and coworkers (31). To this end, melting of
F21T is performed in the presence of three different,
highly selective, G4 ligands: the 360A molecule (38) and
two bisquinolinium compounds Phen-DC(3) and
Phen-DC(6) (39) (see structures in Supplementary Figure
S3), and various competitors: a 26bp duplex (ds26), the
91TRF2G:RNA sequence and its mutant counterpart,
the Mut91TRF2G.
As shown in Table 4, in the presence of sodium or po-
tassium, the three G4 ligands display a good selectivity for
+65 GATCCGCCGAGGAAGCGGCCCGGCCGGGAGGGCGGGGAGGGCGCGCGGCGATCGGACACGGAATTC-ATG
CTAGGCGGCTCCTTCGCCGGGCCGGCCCTCCCGCCCCTCCCGCGCGCCGCTAGCCTGTGCCTTAAG-TAC
+65 GATCCGCCGAGGAAGCGGCCCGGCCGTGAGTGCGCTGAGGGCGCGCGGCGATCGGACACGGAATTC-ATG
CTAGGCGGCTCCTTCGCCGGGCCGGCACTCACGCCACTCCCGCGCGCCGCTAGCCTGTGCCTTAAG-TAC
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Figure 3. Effect of the 91TRF2G sequence on GFP production in vitro.( A) Schematic representation of the plasmids used to investigate the effect of
the 50-UTR sequence of TRF2 mRNA on expression. The plasmids contain 62nt of the 50-UTR TRF2 sequence cloned just upstream of GFP coding
sequence. The plasmid pWUTRF2 carries the wild-type 91TRF2G sequence (underlined) which is replaced by the mutant Mut91TRF2G sequence in
the pMUTRF2 plasmid (modiﬁed nucleotides are not underlined). (B) Expression of the GFP protein in vitro using transcription–translation system.
GFP production was visualized by radioactive signal obtained via [
35S-]methionine incorporation. (C) Histogram representing the ratio of in vitro
GFP production obtained from in vitro transcription and translation of 1mg of pWUTRF2 or pMUTRF2 plasmids. The ratio of the plasmid
pWUTRF2 was set to 1 and the value observed for pMUTRF2 was normalized accordingly. (D) Relative GFP RNA levels for pWUTRF2 and
pMUTRF2 constructs determined by real-time PCR assays. Relative Ct for pWUTRF2 was set to 1 and pMUTRF2 Ct was normalized accordingly.
The results shown are mean values (± SD) from three independent experiments.
7192 Nucleic Acids Research, 2010,Vol.38, No. 20the quadruplex over the control duplex, since stabilization
of F21T is only moderately affected by a 15M excess of
the ds26 DNA duplex. In contrast, when the
91TRF2G:RNA sequence was added, the competition
pattern shows a strong decrease in T1/2 for all com-
pounds. In the presence of sodium or potassium,
91TRF2G:RNA sequence provokes a complete loss of
the stabilization of the F21T by bisquinolinium com-
pounds. For the pyridine dicarboxamide derivate, the
360A molecule, competition analyses show a differential
binding to 91TRF2G:RNA sequence dependent on ionic
conditions. While in the presence of sodium,
91TRF2G:RNA sequence induces a complete displace-
ment of 360A from F21T oligonucleotide; in the
presence of potassium, the G4 ligand presents a lower
afﬁnity for the RNA sequence as compared to F21T
sequence although a signiﬁcant decrease in T1/2 is
observed (T1/2 decreases of 14 C). In contrast, the
mutant sequence, Mut91TRF2G:RNA, did not compete
with the stabilization of F21T by G4 ligands (Table 4).
Together, our results demonstrate that the
91TRF2G:RNA sequence is able to bind G4 ligands and
that the binding to these molecules is associated with its
capacity to adopt a G4 structure.
91TRF2G:RNA G4 structure modulates the expression
of a gene reporter in vitro
To further demonstrate that the repressive effect of
50-UTR 91TRF2G sequence was due to the formation of
a G4 structure, we studied the effect of G4 ligands on GFP
synthesis in vitro.
As shown in Figure 5B, all of the three G4 ligands used
in this assay have a more pronounced effect, concentration
dependent, on GFP expression from the wild-type
(pWUTRF2) than from the mutant construction
(pMUTRF2).
GFP expression from the wild-type construction
(pWUTRF2 containing the 91TRF2G motif), is decreased
by 15 and 60% using 1 and 10mM 360A, respectively
(Figure 5A and B, left). In contrast, up to 10mM 360A
causes a very limited reduction of GFP protein synthesis
of the mutant construction ( 10% at 10mM; Figure 5A
and B, left).
The bisquinolinium compound Phen-DC(3) exhibits a
more marked inhibition effect. At 3mM concentration,
Phen-DC(3) inhibits GFP expression from pWUTRF2
by four-fold, while at the same concentration this
molecule did not show any signiﬁcant effect on
pMUTRF2 construction. Although at 10mM concentra-
tion, Phen-DC(3) showed a marked effect on GFP expres-
sion of from the mutant construction ( 60%), GFP
expression from the wild-type construction was inhibited
by 10-fold (Figure 5B, central).
When compared to the two others molecules,
Phen-DC(6) compound shows a more pronounced
nonspeciﬁc effects. At 3mM, the GFP expression for the
mutant reaches 40% inhibition and this value was of
50% at 10mM. Nevertheless, at the same concentrations,
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Figure 4. Effect of the 91TRF2G motif on translation in human cells. (A) Western blot analysis of GFP expression in 293T cells transfected with
3mg of pWUTRF2 or pMUTRF2 plasmid. Twenty-four hours after transfection, cells were harvested and lysates were prepared. (B) Relative GFP
mRNA levels for pWUTRF2 and pMUTRF2 constructs determined by real-time PCR assays. GFP mRNA levels were normalized to GAPDH and
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Table 4. FRET melting of F21T
T1/2 ( C) No
compound
1mM
Phen-DC(3)
1mM
Phen-DC(6)
1mM
360A
100mM NaCl
No competitor 0.1 27.2 >29.7 25.4
Ds26 0.0 24.0 >28.1 24.0
91TRF2G:RNA 0.6 0.1 0.0 1.0
Mut91TRF2G:RNA  0.5 24.8 >20.6 24.1
10mM KCl + 90mM LiCl
No competitor 0.0 19.2 >31.6 26.5
ds26  0.2 18.3 >31.3 26.5
91TRF2G:RNA  0.5 0.6  0.5 12.0
Mut91TRF2G:RNA  1.4 17.6 >22.4 25.5
The values of melting were determined in presence of G4 ligands and
some competitors. Values represent means from three independent ex-
periments. Compounds were tested at 1mM. Prior to the Tm FRET, the
oligonucleotides were preformed in 10mM lithium cacodylate buffer at
pH 7.2 with 100mM NaCl or 10mM KCl + 90mM LiCl.
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7194 Nucleic Acids Research, 2010,Vol.38, No. 20the inhibition of GFP synthesis from the wild-type con-
struction reaches 75 and 90%, respectively (Figure 5B,
right).
To investigate if the inhibition of the GFP synthesis
induced by G4 ligands was due to a posttranscriptional
effect, we next quantiﬁed the RNA molecules. As shown
in Figure 5C, 10mM 360A did not show any signiﬁcant
effect on RNA production from either pWUTRF2
plasmid or its mutant counterpart pMUTRF2
(Figure 5C, left and right). For Phen-DC(3), a limited
10% inhibition effect was observed only on RNA produc-
tion from pMUTRF2 plasmid. In contrast, Phen-DC(6)
shows a signiﬁcant inhibition effect on RNA production
from both pWUTRF2 and pMUTRF2 plasmids. At
10mM, Phen-DC(6) provokes a 25% inhibition of the
RNA production for both constructions (Figure 5C)
which cannot account for the profound and preferential
inhibition of GFP synthesis observed from the pWUTRF2
plasmid under these conditions (Figure 5B, right).
Together, these results indicate that the inhibition of the
protein production induced by the G4 ligands used in this
report is mainly due to their ability to interfere with a
posttranscriptional process.
DISCUSSION
In the past years, several works have reported the presence
of stable G4 structures in RNA molecules. For instance
RNA G4-forming sequences have been found in the
HIV-genomic RNA, hTERT, FMR1, FGF-2, NRAS,
Zic-1, IGF-II, ESR1 and MT3-MMP mRNAs (40–48).
In this report, we show that a G4-forming sequence,
located 19nt upstream of the initiation codon of the
TRF2 protein, the 91TRF2G sequence, represses protein
synthesis in vitro and is able to reduce the translation rate
of a reporter gene in human cells.
Biophysical studies of the 91TRF2G:RNA sequence
using CD, UV melting and FRET analysis suggest that
the G4 RNA structure is extremely stable and could be
formed under physiological conditions. Remarkably, this
sequence may adopt the features of a stable G4 (typical
G4 CD spectrum and Tm >20 C) for K
+concentrations
as low as 1mM. Native gel electrophoresis, as well as the
independence of the Tm-values over a 10-fold strand con-
centration range, is consistent with the formation of an
intramolecular quadruplex rather than a dimer. The for-
mation of G4 structures is entirely dependent on
Hoogsteen hydrogen bonding established between
guanine nucleotides, and the guanine modiﬁcations
introduced in the mut91TRF2G:RNA sequence complete-
ly abolish the formation of the RNA quadruplex, as
evidenced by CD and UV melting analysis. Interestingly,
the 91TRF2G:RNA sequence is characterized by a ‘Type I
spectra’ with a trough at 240nm and a positive peak at
263nm, which are the main features of parallel G4 struc-
tures (34). Although the structural characterization of this
quadruplex remains to be determined, the parallel folding
of a RNA quadruplex is highly probable due to the more
favored C30-endo conformation of the ribose ring (49),
although a combination of C20-endo and C30-endo has
also been observed (50).
Stable secondary RNA structures located in the
50-UTRs of mRNA have been shown to regulate transla-
tion (51). For example, in bacteria, a RNA G4 motif
located directly upstream of the Shine–Dalgarno
sequence showed a very strong inhibition of the transla-
tion of a reporter gene (52). In human cells, the RNA G4
motif located in the 50-UTR region of Zic-1 and
MT3-MMP mRNAs have been shown to repress transla-
tion (40,46). Furthermore, using in vitro and functional
assays, Halder and coworkers (53) have shown that
natural and synthetic G4 motifs introduced into the
50-UTR region of a mRNA reporter system act as univer-
sal translational suppressors in mammalian cell lines.
In our study, using a GFP reporter system, we show
that the 91TRF2:RNA G4-forming sequence, located in
the 50-UTR region of the TRF2 mRNA, causes a 2.4-fold
decrease of the expression of a reporter gene in vitro and a
2.8-fold decrease in the rate of expression in human cells
(Figures 3 and 4). Interestingly, our results indicate that
the 91TRF2G quadruplex motif does not affect the GFP
mRNA accumulation both in vitro and in cellulo,a s
compared to its mutated counterpart (Figures 3 and 4).
Taken together, these observations show that the G4
motif formed by the 91TRF2G sequence located within
the 50-UTR region of the TRF2 mRNA downregulates
gene expression by a translational suppressor mechanism.
In a previous work, Kumari and colleagues (54)
demonstrated that translation modulation by an RNA
G4-forming sequence is dependent on its position in the
50-UTR of the message, with the inhibition of translation
occurring only when the G4-forming-sequence is rather
proximal to the 50-cap. In our constructions, the G4
motif adopted by the 91TRF2G:RNA sequence is
located at 92 bases downstream of the putative transcrip-
tional start site of T7 polymerase or at 125 bases down-
stream of the putative transcriptional start site of CMV
promoter. Since in the normal context, this sequence is
located closer to the 50-end of the TRF2 mRNA
(90 bases), we can reasonably suppose that its repressive
effect on translation may be at least as efﬁcient as what we
observe with the reporter constructions.
The search for speciﬁc G4 ligands was initially directed
to target DNA telomere repeats and lead to the synthesis
of compounds that present marked effects on telomere
replication and capping (55). Interestingly, these com-
pounds did not present potent selectivity towards other
G4 structures (56), and several reports indicated that
these ligands should not be considered as simple
telomere ‘binders’ (57) and may act in extratelomeric
regions (58,59), or at the mRNA level (60) to modu-
late gene promoter expression (61) and rDNA biosynthe-
sis (62).
The 360A molecule, a pyridine dicarboxamide derivate,
Phen-DC(3) and Phen-DC(6), two bisquinolinium com-
pounds, are three G4 ligands among the most potent
ones reported so far (63). In this study, we demonstrated
that these G4 ligands bind to the 91TRF2G:RNA
sequence and that this binding is dependent on
the ability of this sequence to adopt a G4 structure.
Nucleic Acids Research, 2010,Vol.38, No. 20 7195Thus, as evaluated by competition FRET experiments,
these ligands exhibit a clear afﬁnity for the
91TRF2G:RNA sequence, while they are not able to
bind the mutant counterpart, which did not show the
main features associated to G4 formation (Figure 2).
Using an in vitro coupled transcription–translation
system, we demonstrated that the binding of G4 ligands
to the 91TRF2G:RNA was correlated with their ability to
inhibit the protein synthesis in vitro. Thus, even if at
10mM G4 ligands exhibit an inhibitory effect on the
protein synthesis from the control plasmid pMUTF2
( 20% inhibition for 360A and 60% inhibition for
bisquinolinium compounds): the inhibition effect on the
expression of the GFP protein from the construction con-
taining the G4-forming sequence was  60% for the 360A
and reached 90% for bisquinolinium compounds. In our
assay, bisquinolinium compounds are more active than
the 360A molecule. While, at 1mM 360A molecule has a
limited inhibitory effect on the expression of GFP protein
from pWUTRF2 plasmid, Phen-DC(3) and Phen-DC(6)
inhibit the protein synthesis by two-fold. Interestingly,
competition FRET studies show that, in the presence of
potassium, the binding of 360A to the 91TRF2G:RNA
was weaker than the binding of bisquinolinium com-
pounds to the same sequence (Table 4). When compared
to two others molecules used in this study, Phen-DC(3)
exhibits a more selective effect. At 3mM, Phen-DC(3)
molecule inhibits GFP expression from pWUTRF2 by
four-fold, whereas it does not affect the expression of
the GFP protein from the control plasmid. For compari-
son, the commonly used G4 ligand TMPyP4, show no
RNA G4 speciﬁcity (64), and in a recent publication
Bugaut and coworkers (64) identiﬁed a pyridine-2,6-
bis-quinolino-dicarboxamide derivate, RR82 that
exhibits an two-fold inhibitory effect on NRAS 50-UTR
G4-forming sequence at 10mM concentration.
More interestingly, we demonstrated that G4 ligands
used in this report do not affect the RNA production
and/or stability, as evaluated by RT-PCR analyses
(Figure 5C). Although we cannot exclude that in a
natural chromatin context, the folding of the 91TRF2G
sequence in a G4 structure could also affect the transcrip-
tion of the endogenous TRF2 mRNA; all reports so far
that demonstrate the impact of G4 DNA structures on
transcriptional processes concern G4-forming sequences
located in the promoter regions (13).
Taken together, these observations are consistent
with G4 ligands inhibiting protein synthesis via inter-
actions that stabilize the 91TRF2G:RNA G4 motif.
Furthermore, our study demonstrated the proof-of-
concept for G4 ligand-mediated regulation of translation
by targeting natural G4 RNA motifs.
Mice overexpressing TRF2 in the skin develop both
spontaneous and carcinogenic-induced epithelial tumors
(65). Conversely, downregulation of TRF2 was found to
reduce the tumorigenic potential of grafted tumors in mice
(66). Thus, these studies suggest that the level of TRF2
protein in human cells may play an important role on cell
fate and cancer development. Several reports show that
TRF2 is overexpressed in human tumors (24–26).
Although most of these works have evaluated TRF2
expression at the mRNA level, Nijjar and coworkers
(25) have shown that the upregulation of the TRF2
protein in tumor cells, as compared to normal cells
results from differences in posttranscriptional regulation,
since their mRNA levels remained comparable. According
to the data reported here, it may be interesting to check if
G4-forming sequences in TRF2 mRNA could be
implicated in part of the changes in TRF2 protein level
associated with cancer.
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